As filed with the Securities and Exchange Commission on September 11, 2015
Registration No. 333-124187
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
POST-EFFECTIVE AMENDMENT NO. 1
TO
FORM S-8
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
BIO-RAD LABORATORIES, INC.
(Exact name of registrant as specified in its charter)
Delaware | 1000 Alfred Nobel Drive Hercules, CA 94547 |
94-1381833 | ||
(State or other jurisdiction of incorporation or organization) |
(Address, including zip code, of Principal Executive Offices) |
(I.R.S. Employer Identification No.) |
THE 2003 STOCK OPTION PLAN
OF BIO-RAD LABORATORIES, INC.
(Full title of the plan)
Shawn M. Soderberg, Esq.
Executive Vice President, General Counsel and Secretary
BIO-RAD LABORATORIES, INC.
1000 Alfred Nobel Drive
Hercules, CA 94547
(510) 724-7000
(Name, address and telephone number, including area code, of agent for service)
Copies to:
Tad J. Freese, Esq.
Latham & Watkins LLP
140 Scott Drive
Menlo Park, CA 94025
(650) 328-4600
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer | x | Accelerated filer | ¨ | |||
Non-accelerated filer | ¨ (Do not check if a smaller reporting company) | Smaller reporting company | ¨ |
PARTIAL DEREGISTRATION OF SHARES OF COMMON STOCK
This Post-Effective Amendment No. 1 relates to the Registration Statement on Form S-8 (File No. 333-124187) (the Registration Statement) filed by Bio-Rad Laboratories, Inc. (the Company). The Registration Statement registered shares of the Companys Class A and Class B Common Stock, $0.0001 par value (Common Stock), issuable pursuant to the 2003 Stock Option Plan of the Company (the 2003 Plan).
This Post-Effective Amendment No. 1 is being filed for the sole purpose of deregistering 824,360 unissued shares of Common Stock (consisting of 659,550 shares of Class A Common Stock and 164,810 shares of Class B Common Stock) previously registered under the Registration Statement and issuable under the 2003 Plan. The Company hereby removes from registration, by means of this Post-Effective Amendment No. 1 to the Registration Statement, 824,360 unissued shares of Common Stock (consisting of 659,550 shares of Class A Common Stock and 164,810 shares of Class B Common Stock) previously registered under the Registration Statement.
1
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment No. 1 to Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Hercules, State of California, on this 11th day of September 2015.
BIO-RAD LABORATORIES, INC. | ||
By: | /s/ Christine A. Tsingos | |
Christine A. Tsingos | ||
Executive Vice President, Chief Financial Officer |
Pursuant to the requirements of the Securities Act of 1933, as amended, this Post-Effective Amendment No. 1 to Registration Statement has been signed by the following persons in the capacities indicated on September 11, 2015.
/s/ Norman Schwartz (Norman Schwartz) |
Chairman of the Board, President and Chief Executive Officer | |
/s/ Christine A. Tsingos (Christine A. Tsingos) |
Executive Vice President, Chief Financial Officer | |
/s/ James R. Stark (James R. Stark) |
Vice President, Corporate Controller |
Other Directors:
/s/ Louis Drapeau (Louis Drapeau) |
Director | |
(Robert M. Malchione) |
Director | |
/s/ Joel McComb (Joel McComb) |
Director | |
/s/ Deborah J. Neff (Deborah J. Neff) |
Director | |
/s/ Alice N. Schwartz (Alice N. Schwartz) |
Director |